- Associated Press - Friday, August 21, 2015

ST. PAUL, Minn. (AP) - Minnesota’s share of a $71 million multistate settlement with biotech drugmaker Amgen tops $1.2 million.

The deal to end an investigation into illegal marketing of two drugs made by the company was announced earlier this week. Court papers filed in Minnesota say the state’s portion will go toward individuals who experienced harm, administrative costs and the general treasury if any is left.

Forty-eight states and Washington D.C. reached the agreement with Amgen, the maker of drugs to treat anemia in cancer patients and ailments like plaque psoriasis.

The company says the settlement isn’t an admission of guilt or wrongdoing.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide